Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography
- 1 May 1980
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 182 (2) , 211-220
- https://doi.org/10.1016/s0378-4347(00)81625-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Multicompartment Pharmacokinetic Model of 4′-Demethylepipodophyllotoxin 9-(4,6-O-Ethylidene- β-D-glucopyranoside) in HumansJournal of Pharmaceutical Sciences, 1978
- The Role of Drug Disposition Kinetics on Cellular Transport of the Antineoplastic Agent VM-26Drug Metabolism Reviews, 1978
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- Nonenolizable podophyllotoxin derivativesJournal of Medicinal Chemistry, 1977
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesPublished by Elsevier ,1975
- PTG, a new antineoplastic epipodophyllotoxinClinical Pharmacology & Therapeutics, 1975
- EPEG, a new antineoplastic epipodophyllotoxinClinical Pharmacology & Therapeutics, 1975
- Mitosis-inhibiting natural products. 24. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxinJournal of Medicinal Chemistry, 1971
- A Laboratory Procedure for the Acetylation and Permethylation of Oligopeptides on the Microgram ScaleAnalytical Letters, 1971
- The Podophyllotoxin—Picropodophyllin Equilibrium1,2The Journal of Organic Chemistry, 1966